| 2022-11-03 | +26.2% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2025-08-05 | -19.2% | earnings | Seeking Alpha | Mesa Laboratories GAAP EPS of $0.85 beats by $0.41, revenue of $59.54M misses by $1.03M |
| 2025-08-05 | -19.2% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2026-03-09 | -16.6% | executive | MT Newswires | Mesa Laboratories Names Siddhartha Kadia as President and CEO |
| 2026-03-09 | -16.6% | executive | GlobeNewswire | Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO |
| 2026-03-09 | -16.6% | executive | Seeking Alpha | Mesa Laboratories names new CEO |
| 2026-03-09 | -16.6% | legal | SEC EDGAR | MLAB 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-09 | -16.6% | executive | Stock Titan | Mesa leadership shift: Gary Owens exits, Siddhartha Kadia takes CEO role - Stock Titan |
| 2026-02-03 | +15.0% | earnings | Associated Press Finance | Mesa Labs: Fiscal Q3 Earnings Snapshot |
| 2026-02-03 | +15.0% | news | GlobeNewswire | Mesa Labs Announces Third Quarter Results |
| 2026-02-03 | +15.0% | earnings | Seeking Alpha | Mesa Laboratories GAAP EPS of $0.65 beats by $0.37, revenue of $65.13M beats by $1.9M |
| 2026-02-03 | +15.0% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2026-02-03 | +15.0% | news | TradingView | Mesa Labs Announces Third Quarter Results - TradingView |
| 2024-02-14 | +13.2% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-11-07 | -12.6% | earnings | Seeking Alpha | Mesa Laboratories reports Q2 results |
| 2024-11-07 | -12.6% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2024-06-05 | +12.1% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2025-07-04 | -9.4% | news | Seeking Alpha | Mesa Laboratories: Strong Order Growth And Positive Valuation Outlook |
| 2023-08-03 | +8.7% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2026-01-08 | -8.3% | news | Seeking Alpha | Mesa Laboratories declares $0.16 dividend |
| 2023-02-06 | -8.1% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2024-08-05 | +7.8% | earnings | Seeking Alpha | Mesa Laboratories Non-GAAP EPS of $2.58, revenue of $58.17M |
| 2024-08-05 | +7.8% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2026-03-10 | -7.8% | news | Seeking Alpha | Mesa Laboratories: Hard To Set The Right Diagnosis |
| 2026-03-10 | -7.8% | news | Seeking Alpha | Mesa Laboratories: Hard To Set The Right Diagnosis (NASDAQ:MLAB) - Seeking Alpha |
| 2025-07-03 | -7.7% | news | Seeking Alpha | Mesa Laboratories declares $0.16 dividend |
| 2025-11-07 | +7.6% | news | Yahoo Finance | Mesa Laboratories, Inc. (NASDAQ:MLAB) is a favorite amongst institutional investors who own 87% - Yahoo Finance |
| 2025-05-28 | -7.4% | earnings | Seeking Alpha | Mesa Laboratories Non-GAAP EPS of $2.25 beats by $0.18, revenue of $62.14M beats by $0.24M |
| 2025-05-28 | -7.4% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2022-11-04 | +6.1% | legal | SEC EDGAR | MLAB 8-K: 5.02 (SEC Filing) |
| 2026-04-02 | +6.0% | earnings | GlobeNewswire | MESA LABS DECLARES QUARTERLY DIVIDEND |
| 2026-04-02 | +6.0% | earnings | Stock Titan | Mesa Labs sets June 15 payout for $0.16 quarterly dividend - Stock Titan |
| 2026-04-02 | +6.0% | executive | Stock Titan | Mesa Laboratories (MLAB) CEO RSUs expire as 8,211 units forfeited - Stock Titan |
| 2021-09-14 | +5.8% | legal | SEC EDGAR | MLAB 8-K: 1.01, 7.01 (SEC Filing) |
| 2024-04-08 | +5.7% | legal | SEC EDGAR | MLAB 8-K: 1.01, 7.01, 8.01 (SEC Filing) |
| 2025-08-09 | -5.7% | news | simplywall.st | Mesa Laboratories (NASDAQ:MLAB investor five-year losses grow to 73% as the stock sheds US$58m this past week - simplywall.st |
| 2023-06-08 | -5.3% | earnings | Seeking Alpha | Mesa Laboratories: No Economic Earnings At 18x EBIT Is A Tough Ask (NASDAQ:MLAB) - Seeking Alpha |
| 2026-04-22 | -5.3% | earnings | MarketBeat | Mesa Laboratories (NASDAQ:MLAB) Share Price Crosses Above 200-Day Moving Average - Should You Sell? - MarketBeat |
| 2026-04-22 | -5.3% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Mesa Laboratories (MLAB) Stock: Trend Analysis (Touches High) 2026-04-22 - Real Trader Insights - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-22 | -5.3% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | What factors could change Mesa Laboratories (MLAB) stock direction | Q1 2026: Better Than Expected - Revenue Growth Rate - Cổng thông tin điện tử tỉnh Lào Cai |
| 2022-08-04 | -5.3% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2024-04-05 | +4.9% | earnings | Seeking Alpha | Mesa Laboratories maintains quarterly dividend of $0.16 |
| 2025-06-20 | +4.8% | legal | Stock Titan | MLAB SEC Filings - Mesa Laboratories 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2021-06-01 | +4.7% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2026-04-10 | +4.5% | news | Cổng thông tin điện tử Tỉnh Sơn La | How expensive is Mesa Laboratories (MLAB) Stock now | Price at $95.05, Up 2.39% - Entry Points - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-10 | +4.5% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | Is Mesa Laboratories (MLAB) Stock overvalued relative to peers | MLAB Q4 Earnings: Beats Estimates by $0.37 - Verified Stock Signals - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2023-05-25 | -4.4% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2023-10-16 | +4.3% | earnings | Seeking Alpha | Mesa Labs buys three GKE entities for 85M to boost revenue |
| 2023-10-10 | +4.1% | legal | SEC EDGAR | MLAB 8-K: 1.01, 2.03 (SEC Filing) |
| 2021-10-21 | -3.9% | legal | SEC EDGAR | MLAB 8-K: 2.01, 2.03, 7.01 (SEC Filing) |
| 2026-01-07 | -3.8% | news | Stock Titan | This Colorado lab company is sending cash straight to its shareholders - Stock Titan |
| 2026-04-21 | -3.7% | news | Cổng thông tin điện tử Tỉnh Sơn La | Mesa Laboratories (MLAB) Stock: Risks and Potential (Smart Money Flows) 2026-04-20 - Hedge Fund Inspired Picks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-23 | -3.7% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | What factors could change Mesa Laboratories (MLAB) stock direction | Q1 2026: Better Than Expected - Interest Coverage - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-02-18 | +3.6% | news | GlobeNewswire | As Worker Safety Scrutiny Intensifies, Mesa Labs Reinforces Why Primary Standard Calibration Is the Only Line of Defense |
| 2025-11-06 | +3.4% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2023-05-08 | -3.3% | legal | SEC EDGAR | MLAB 8-K: 5.02 (SEC Filing) |
| 2026-01-11 | +3.3% | news | simplywall.st | Mesa Laboratories (NASDAQ:MLAB) Has Affirmed Its Dividend Of $0.16 - simplywall.st |
| 2025-07-20 | -3.2% | news | simplywall.st | It's Down 27% But Mesa Laboratories, Inc. (NASDAQ:MLAB) Could Be Riskier Than It Looks - simplywall.st |
| 2021-11-04 | +3.2% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2026-04-03 | +3.0% | news | Seeking Alpha | Mesa Laboratories declares a $0.16 dividend |
| 2026-04-06 | +2.9% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is Mesa Laboratories (MLAB) Stock Consolidating | Price at $92.49, Up 1.55% - Community Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2023-08-24 | +2.8% | analyst | Seeking Alpha | Mesa Laboratories: Continued Pressure On Equity Re-Rating, Reiterate Hold |
| 2025-02-04 | +2.6% | earnings | Seeking Alpha | Mesa Laboratories Non-GAAP EPS of $2.72 beats by $1.21, revenue of $62.84M beats by $4.01M |
| 2025-02-04 | +2.6% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2022-05-31 | -2.3% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2024-05-23 | -2.3% | news | TradingView | MLAB Stock Price and Chart — NASDAQ:MLAB - TradingView |
| 2026-02-20 | +2.3% | news | Insider Monkey | Here’s Why Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) |
| 2026-02-20 | +2.3% | news | Yahoo Finance | Here’s Why Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) - Yahoo Finance |
| 2022-03-30 | +2.2% | legal | SEC EDGAR | MLAB 8-K: 8.01 and (SEC Filing) |
| 2024-02-05 | +2.1% | earnings | Seeking Alpha | Mesa Laboratories Non-GAAP EPS of $2.02 beats by $0.32, revenue of $53.47M misses by $1.13M |
| 2024-02-05 | +2.1% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2026-01-15 | +2.0% | news | Seeking Alpha | Mesa Laboratories, Inc. (MLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow |
| 2026-01-15 | +2.0% | news | Seeking Alpha | Mesa Laboratories, Inc. (MLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2023-12-14 | +2.0% | analyst | eToro | MLAB Stock Price | Analyst Target 104.50 & Consensus - eToro |
| 2024-01-04 | +2.0% | news | Seeking Alpha | Mesa Laboratories declares $0.16 dividend |
| 2022-02-03 | -2.0% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2025-11-25 | +1.9% | news | Seeking Alpha | Mesa Laboratories: Appealing Territory Has Been Reached |
| 2025-11-25 | +1.9% | news | Seeking Alpha | Mesa Laboratories: Appealing Territory Has Been Reached (NASDAQ:MLAB) - Seeking Alpha |
| 2022-04-11 | +1.9% | legal | SEC EDGAR | MLAB 8-K: 5.02 (SEC Filing) |
| 2024-01-08 | +1.8% | legal | SEC EDGAR | MLAB 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-08-15 | +1.5% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Mesa Laboratories (MLAB) - Zacks Investment Research |
| 2022-04-05 | -1.4% | legal | SEC EDGAR | MLAB 8-K: 1.01 and (SEC Filing) |
| 2021-09-03 | +1.3% | legal | SEC EDGAR | MLAB 8-K: 5.02 (SEC Filing) |
| 2026-04-15 | -1.3% | news | Stock Titan | Long Path discloses 7.3% stake in Mesa Labs (NASDAQ: MLAB) - Stock Titan |
| 2026-02-05 | +1.3% | news | Simply Wall St. | Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock? |
| 2026-02-05 | +1.3% | news | Yahoo Finance | Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock? - Yahoo Finance |
| 2026-03-24 | +1.2% | executive | The Globe and Mail | Mesa Laboratories CEO Gary Owens Announces Planned Departure - The Globe and Mail |
| 2021-07-22 | -1.2% | earnings | Zacks Investment Research | What date does Mesa Laboratories's (MLAB) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research |
| 2024-07-08 | +1.2% | news | Seeking Alpha | Mesa Laboratories declares $0.16 dividend |
| 2025-12-03 | +1.0% | earnings | Stock Titan | Mesa Laboratories (NASDAQ: MLAB) schedules Feb. 3 FY 2026 Q3 financial results release - Stock Titan |
| 2025-01-06 | +1.0% | news | Seeking Alpha | Mesa Laboratories declares $0.16 dividend |
| 2021-09-29 | +0.9% | legal | SEC EDGAR | MLAB 8-K: 5.02 and (SEC Filing) |
| 2023-10-03 | -0.9% | news | Seeking Alpha | Mesa Laboratories declares $0.16 dividend |
| 2025-04-07 | -0.8% | news | Seeking Alpha | Mesa Laboratories declares $0.16 dividend |
| 2024-12-19 | +0.8% | M&A | Seeking Alpha | Mesa Laboratories: GKE Acquisition New Crown Jewel, Still Doesn't Move The Needle |
| 2021-12-23 | -0.7% | legal | SEC EDGAR | MLAB 8-K: 8.01 and (SEC Filing) |
| 2026-03-23 | +0.7% | legal | SEC EDGAR | MLAB 8-K: 5.02 and (SEC Filing) |
| 2026-03-23 | +0.7% | executive | Stock Titan | Mesa Laboratories (NASDAQ: MLAB) sets CEO Owens transition and board exit - Stock Titan |
| 2025-10-03 | +0.6% | news | Seeking Alpha | Mesa Laboratories declares $0.16 dividend |
| 2026-04-20 | -0.5% | news | Simply Wall St. | Undervalued Small Caps With Insider Buying Across Regions To Consider |
| 2023-11-06 | -0.4% | earnings | Seeking Alpha | Mesa Laboratories Non-GAAP EPS of $1.91 beats by $0.12, revenue of $53.17M misses by $1.48M |
| 2023-11-06 | -0.4% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2021-08-05 | -0.4% | legal | SEC EDGAR | MLAB 8-K: 2.02 and (SEC Filing) |
| 2024-10-02 | +0.3% | news | Seeking Alpha | Mesa Laboratories declares $0.16 dividend |
| 2024-08-16 | +0.3% | news | Yahoo Finance | Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) Due to Inconsistent Performance - Yahoo Finance |
| 2023-08-21 | -0.2% | news | Seeking Alpha | Mesa Laboratories (MLAB) Investor Presentation - Slideshow |
| 2022-06-27 | -0.1% | legal | SEC EDGAR | MLAB 8-K: 5.02 and (SEC Filing) |
| 2021-10-29 | -0.1% | legal | SEC EDGAR | MLAB 8-K: 5.02 and (SEC Filing) |
| 2025-04-03 | -0.0% | news | Seeking Alpha | Mesa Laboratories: Green Shoots Emerge |
| 2026-04-24 | — | executive | Stock Titan | Mesa Laboratories (MLAB) CEO receives 34,807 RSU equity award - Stock Titan |
| 2026-04-24 | — | executive | Stock Titan | Mesa Labs (MLAB) CEO Kadia files Form 3 with no insider trades - Stock Titan |